Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

TORONTO, July 02, 2024 (GLOBE NEWSWIRE) -- Probe Gold Inc. (TSX: PRB) (OTCQB: PROBF) (“ Probe ” or the “ Company ”) is pleased to announce the appointment of Marc Ducharme as Vice President of Exploration, effective immediately. Mr. Marc...

TORONTO, July 02, 2024 (GLOBE NEWSWIRE) -- Probe Gold Inc. (TSX: PRB) (OTCQB: PROBF) (“ Probe ” or the “ Company ”) is pleased to announce the appointment of Marc Ducharme as Vice President of Exploration, effective immediately. Mr. Marc...

PURCHASE, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, today announced that abstracts summarizing clinical e...

Calgary, Alberta--(Newsfile Corp. - July 2, 2024) - North Peak Resources Ltd. (TSXV: NPR) (the " Company " or " North Peak ") announces that drilling is underway at its Prospect Mountain North area, with the first hole to be drilled now completed. The roughly 10,000 foot r/c drill campaign is t...

First ore to Kipushi concentrator achieved on May 31; first concentrate produced on June 14 Kipushi sets 2024 production guidance at between 100,000 and 140,000 tonnes of zinc in concentrate Kipushi zinc production capacity to average 278,000 tonnes per annum over first five years, making K...

116 patients enrolled June represents a new record breaking month for patient enrollment TORONTO, July 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing ther...

MONTREAL, July 02, 2024 (GLOBE NEWSWIRE) -- Bombardier expects its supply contracts to be maintained to the highest standards of quality and performance. The company remains actively engaged with Spirit as part of ordinary course of business under existing contracts. About Bombardier ...

MONTREAL, July 02, 2024 (GLOBE NEWSWIRE) -- Bombardier expects its supply contracts to be maintained to the highest standards of quality and performance. The company remains actively engaged with Spirit as part of ordinary course of business under existing contracts. About Bombardier ...

AUSTIN, Texas, July 02, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS...

Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events PR Newswire Two abstracts accepted for oral presentation at the 13 th London International Cough Symposium NEW HAVEN, Conn. , July 2, 2024 /PRNewswire/ -- Trevi Therapeutic...